Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Par naproxen tablets being supplied by MOVA following April 28 ANDA.

Executive Summary

PAR PHARMACEUTICALS DISTRIBUTING MOVA's NAPROXEN TABLETS following approval of the generic analgesic April 28, Caugas, Puerto Rico-based MOVA said May 5. Par will market naproxen 250, 375 and 500 mg tablets under an agreement with MOVA announced in October 1994. Par already distributes MOVA's albuterol sulfate 2mg/5 ml syrup, approved on Sept. 30, under the agreement.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026169

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel